XBiotech is a biopharmaceutical company that develops antibody therapies for inflammatory diseases and colorectal cancer...
Read moreXBiotech is a biopharmaceutical company that develops antibody therapies for inflammatory diseases and colorectal cancer...
Read moreAnnual Revenue
$8.2M
XBiotech's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 3.6B. Over the last four quarters, XBiotech's revenue has decreased by 62.7%. Specifically, in Q3 2022's revenue was $1.7M; in Q2 2022, it was $1.5M; in Q1 2022, it was $ < 1M; in Q4 2021, XBiotech's revenue was $4.5M.